Experimental Section
Preparation of RBC Membrane-Coated Nanoparticles (RBC-NPs). RBCs were collected from 10 week-old male ICR mice (Charles River Laboratories) by centrifuging the whole blood at 2000 x g for 5 min, following which the supernatant and buffy coat were removed. Collected RBCs were then subject to hypotonic treatment to remove interior contents. The resulting RBC ghosts were extruded through 100 nm polycarbonate porous membranes using an extruder (Avanti Polar Lipids) to prepare RBC membrane-derived vesicles with a diameter of approximately 120 nm. Poly(lactic-co-glycolic acid) (PLGA) polymeric cores were prepared using 0.67 dL/g carboxy-terminated 50:50 PLGA polymer (LACTEL Absorbable Polymers) through a solvent displacement process, during which 1 mg of PLGA was dissolved in 200 μL of acetone and added drop-wise to 3 mL of water. Following solvent evaporation for 2 hr, the particles were washed using 10 kDa molecular weight cutoff (MWCO) Amicon Ultra-4
Centrifugal Filters (Millipore). The RBC-NPs were then prepared by fusing the RBC membranederived vesicles onto the PLGA particles by extruding the particles with the RBC membranederived vesicles through 100 nm polycarbonate porous membranes. The size and the zeta potential of the resulting RBC-NPs were obtained from three dynamic light scattering (DLS) measurements using a Malvern ZEN 3600 Zetasizer, which showed an average hydrodynamic diameter of 70 and 85 nm before and after the extrusion process, respectively ( Figure S1 ). The particle morphology was characterized using scanning electron microscopy (SEM). Samples for SEM imaging were prepared by dropping 5 µL of the RBC-NP solution onto a polished silicon wafer. After drying the droplet at room temperature overnight, the sample was coated with chromium and then imaged by SEM. following the manufacturer's instructions and imaged using a gel imager. For CD47 identification, the resulting gel was transferred to a nitrocellulose membrane. The membrane was then stained with a primary rat anti-mouse CD47 antibody (BD Biosciences) and a secondary goat anti-rat IgG HRP conjugate (Millipore). The membrane was then subject to ECL western blotting substrate (Pierce) and developed with the Mini-Medical/90 Developer (ImageWorks).
Identification of Membrane

Quantification of CD47 on the RBC-NPs:
The amount of CD47 retained on the RBC-NPs was quantified by comparing the CD47 protein intensity to protein standards prepared on the same western blotting membrane. The protein standards were prepared from predetermined volumes of blood, which yielded a positive linear correlation between the CD47 band intensity and the blood volume following western blotting ( Figure S2 ). The band intensities were quantified through an image analysis with Adobe Photoshop software. A CD47 standard curve was then established by converting the blood volumes to their corresponding CD47 quantity, using an estimated concentration of mouse RBCs in the blood (10 10 /mL) 1 and an average number of CD47 per mouse RBC (16,500 copies/cell) 2 ( Figure S2 ).
Immunostaining and Negative Staining for Transmission Electron Microscopy (TEM)
Imaging: A drop of the RBC-NP or bare PLGA nanoparticle (bare NP) solution (1 mg/mL) was deposited onto a glow-discharged carbon-coated grid. For immunostaining, the sample droplet was washed with 3 drops of 0.5 mg/mL rat anti-mouse CD47 antibody solution. For staining CD47's intracellular domains, a rabbit anti-CD47 antibody (GeneTex) that specifically targets an intracellular sequence of CD47 was used. Following 30 sec of incubation, the sample was rinsed 
